Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)
Nicole S Bartosh, Tara Tomlin, Christian Cable, Kathleen HalkaDepartment of Internal Medicine, Division of Medical Oncology, Scott and White Healthcare and Texas A and M Health Science Center College of Medicine, Temple, TX, USAAbstract: This case report presents a newly diagnosed congenital factor...
Guardado en:
Autores principales: | Bartosh NS, Tomlin T, Cable C, Halka K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b4bf932b092349148cf13a2e0d2f0491 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
por: Amir M. Ansari, et al.
Publicado: (2021) -
Novanglus, No. VII
Publicado: (2017) -
Resolución 130(VII): Energía nuclear = Resolution 130(VII): Nuclear energy = Résolution 130(VII): Energie nucléaire
Publicado: (2014) -
Resolución 125(VII): Asistencia técnica = Resolution 125(VII): Technical assistance = Résolution 125(VII): Assistance technique
Publicado: (2014) -
Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging
por: Liu H, et al.
Publicado: (2016)